UBS Group’s EnteroMedics Inc. ETRM Stock Holding History

UBS Group’s Portfolio ETRM Stock Details ETRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-2	Closed	-$1K	–	9387
2015 Q1	$1K	Hold	2	–	–	﹤0.01%	8697
2014 Q4	$4K	Buy	+2	New	+$2.7K	﹤0.01%	9202

Other funds holding ETRM

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

UBS Group's ETRM Position: Q4 2017 in Review

UBS Group sold out of EnteroMedics Inc. (ETRM) in Q4 2017, closing a stake of 1,940 shares — an estimated $3K sold.

UBS Group first reported a position in ETRM in Q4 2014 and held it in 11 quarters. The position peaked at $53K in Q1 2017. 1 fund tracked by Wall St. Rank holds ETRM as of Q4 2017.

UBS Group reported no remaining EnteroMedics Inc. position as of Q4 2017 after selling out during the quarter.
UBS Group sold 1,940 EnteroMedics Inc. shares in Q4 2017, an estimated $3K.
UBS Group first reported a position in EnteroMedics Inc. in Q4 2014 and held it in 11 quarters.
UBS Group's EnteroMedics Inc. position peaked at $53K in Q1 2017.
1 fund tracked by Wall St. Rank held EnteroMedics Inc. as of Q4 2017.

Based on UBS Group's 13F filing for Q4 2017, filed 14 Feb 2018.